Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

GRECOS Project (Genotyping Recurrence Risk of Stroke): the use of genetics to predict the vascular recurrence after stroke

  • Fernández-Cadenas, Israel
  • Mendióroz, Maite
  • Giralt, Dolors
  • Nafria, Cristina
  • García, Elena
  • Carrera, Caty
  • Gallego-Fábrega, Cristina
  • Domingues-Montanari, Sophie
  • Delgado, Pilar
  • Ribó, Marc
  • Castellanos, María del Mar
  • Martínez, Sergi
  • Freijo Guerrero, María del Mar
  • Jiménez-Conde, Jordi
  • Rubiera, Marta
  • Álvarez-Sabín, José
  • Molina, Carlos A.
  • Font, María A.
  • Grau Olivares, Marta
  • Palomeras, Ernest
  • Pérez de la Ossa, Natalia
  • Martínez-Zabaleta, Maite
  • Masjuan, Jaime
  • Moniche, Francisco
  • Cánovas, David
  • Piñana, Carlos
  • Purroy, Francisco
  • Cocho, Dolores
  • Navas, Inma
  • Tejero Juste, Carlos
  • Aymerich, Nuria
  • Cullell, Natalia
  • Muiño, Elena
  • Serena, Joaquín
  • Rubio, Francisco
  • Dávalos, Antoni
  • Roquer, Jaume
  • Arenillas, Juan
  • Martí-Fàbregas, Joan
  • Keene, Keith
  • Chen, Wei-Min
  • Worrall, Bradford B.
  • Sale, Michele
  • Arboix, Adriá
  • Krupinski, Jerzy
  • Montaner, Joan
[Abstract] Background and purpose: Vascular recurrence occurs in 11% of patients during the first year after ischemic stroke (IS) or transient ischemic attack. Clinical scores do not predict the whole vascular recurrence risk; therefore, we aimed to find genetic variants associated with recurrence that might improve the clinical predictive models in IS. Methods: We analyzed 256 polymorphisms from 115 candidate genes in 3 patient cohorts comprising 4482 IS or transient ischemic attack patients. The discovery cohort was prospectively recruited and included 1494 patients, 6.2% of them developed a new IS during the first year of follow-up. Replication analysis was performed in 2988 patients using SNPlex or HumanOmni1-Quad technology. We generated a predictive model using Cox regression (GRECOS score [Genotyping Reurrence Risk of Stroke]) and generated risk groups using a classification tree method. Results: The analyses revealed that rs1800801 in the MGP gene (hazard ratio, 1.33; P=9×10-03), a gene related to artery calcification, was associated with new IS during the first year of follow-up. This polymorphism was replicated in a Spanish cohort (n=1.305); however, it was not significantly associated in a North American cohort (n=1.683). The GRECOS score predicted new IS (P=3.2×10-09) and could classify patients, from low risk of stroke recurrence (1.9%) to high risk (12.6%). Moreover, the addition of genetic risk factors to the GRECOS score improves the prediction compared with previous Stroke Prognosis Instrument-II score (P=0.03). Conclusions: The use of genetics could be useful to estimate vascular recurrence risk after IS. Genetic variability in the MGP gene was associated with vascular recurrence in the Spanish population., This study was funded by Marato TV3, by the Spanish stroke research network (INVICTUS-PLUS) and by Generacion project (PI15/01978) Instituto de Salud Carlos III. I. F-C. is supported by the Miguel Servet programme (CP12/03298), Instituto de Salud Carlos III. Several groups participate in the International Stroke Genetics Consortium and the Spanish Stroke Genetics Consortium. The Hospital del Mar is supported by Spain’s Ministry of Health (III FEDER, RD12/0042/0020) Study recruitment and collection of datasets for the VISP trial were supported by a grant (R01 NS34447; PI James Toole) from the National Institute of Neurological Disorders and Stroke (NINDS). GWAS genotyping (U01 HG004438l; PI David Valle), funded by the National Human Genome Research institute and the Genomics and Randomized Trials (GARNET) Network (U01HG00516-03; co-PI Michèle M Sale & Bradford B Worrall), and genetic data cleaning was provided by the GARNET Coordinating Center (U01HG005157; PI Bruce S. Weir).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Automated quantification of cerebral edema following hemispheric infarction, Application of a machine-learning algorithm to evaluate CSF shifts on serial head CTs

  • Chen, Yasheng
  • Dhar, Rajat|||0000-0002-5167-5097
  • Heitsch, Laura
  • Ford, Andria
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Carrera, Caty|||0000-0002-0804-0969
  • Montaner, Joan|||0000-0003-4845-2279
  • Lin, Weili
  • Shen, Dinggang
  • An, Hongyu
  • Lee, Jin-Moo
Although cerebral edema is a major cause of death and deterioration following hemispheric stroke, there remains no validated biomarker that captures the full spectrum of this critical complication. We recently demonstrated that reduction in intracranial cerebrospinal fluid (CSF) volume (∆ CSF) on serial computed tomography (CT) scans provides an accurate measure of cerebral edema severity, which may aid in early triaging of stroke patients for craniectomy. However, application of such a volumetric approach would be too cumbersome to perform manually on serial scans in a real-world setting. We developed and validated an automated technique for CSF segmentation via integration of random forest (RF) based machine learning with geodesic active contour (GAC) segmentation. The proposed RF + GAC approach was compared to conventional Hounsfield Unit (HU) thresholding and RF segmentation methods using Dice similarity coefficient (DSC) and the correlation of volumetric measurements, with manual delineation serving as the ground truth. CSF spaces were outlined on scans performed at baseline (< 6 h after stroke onset) and early follow-up (FU) (closest to 24 h) in 38 acute ischemic stroke patients. RF performed significantly better than optimized HU thresholding (p < 10 - 4 in baseline and p < 10 - 5 in FU) and RF + GAC performed significantly better than RF (p < 10 - 3 in baseline and p < 10 - 5 in FU). Pearson correlation coefficients between the automatically detected ∆ CSF and the ground truth were r = 0.178 (p = 0.285), r = 0.876 (p < 10 - 6) and r = 0.879 (p < 10 - 6) for thresholding, RF and RF + GAC, respectively, with a slope closer to the line of identity in RF + GAC. When we applied the algorithm trained from images of one stroke center to segment CTs from another center, similar findings held. In conclusion, we have developed and validated an accurate automated approach to segment CSF and calculate its shifts on serial CT scans. This algorithm will allow us to efficiently and accurately measure the evolution of cerebral edema in future studies including large multi-site patient populations.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GRECOS project (Genotyping Recurrence Risk of Stroke). The use of genetics to predict the vascular recurrence after stroke

  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Mendioroz, Maite|||0000-0002-4179-5781
  • Giralt, Dolors
  • Nafría, Cristina
  • Garcia, Elena
  • Carrera, Caty|||0000-0002-0804-0969
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Domingues-Montanari, Sophie
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Ribo, Marc|||0000-0001-9242-043X
  • Castellanos, María del Mar|||0000-0003-3116-1352
  • Martínez, Sergi
  • Freijo, Mari Mar
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Rubiera, Marta
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Molina, Carlos A.|||0000-0001-6058-6259
  • Font, Maria Angels
  • Grau Olivares, Marta
  • Palomeras, Ernest|||0000-0002-0724-8653
  • Pérez de la Ossa, Natalia|||0000-0002-6063-211X
  • Martinez Zabaleta, Maite
  • Masjuan, Jaime|||0000-0003-1329-0943
  • Moniche, Francisco|||0000-0001-8613-2909
  • Cánovas Verge, David|||0000-0002-3483-8106
  • Piñana, Carlos|||0000-0001-7316-6202
  • Purroy, Francisco|||0000-0002-1808-5968
  • Cocho, Dolores
  • Navas, Inmaculada
  • Tejero, Carlos
  • Aymerich, Nuria
  • Cullell, Natalia|||0000-0001-5118-1014
  • Muiño, Elena|||0000-0001-5839-7328
  • Serena, Joaquín|||0000-0002-4478-7744
  • Rubio, Francisco
  • Dávalos, Antoni|||0000-0003-2949-5679
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Keene, Keith
  • Chen, Wei-Min
  • Worrall, Bradford
  • Sale, Michele
  • Arboix, Adrià|||0000-0002-8512-7881
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Montaner, Joan|||0000-0003-4845-2279
Background and Purpose-Vascular recurrence occurs in 11% of patients during the first year after ischemic stroke (IS) or transient ischemic attack (TIA). Clinical scores do not predict the whole vascular recurrence risk, therefore we aimed to find genetic variants associated with recurrence that might improve the clinical predictive mode is in IS. Methods-We analyzed 256 polymorphisms from 115 candidate genes in three patient cohorts comprising 4,482 IS or TIA patients. The discovery cohort was prospectively recruited and included 1,494 patients, 6.2% of them developed a new IS during the first year of follow-up. Replication analysis was performed in 2,988 patients using SNPlex or HumanOmni1-Quad technology. We generated a predictive model using Cox regression (GRECOS score), and generated risk groups using a classification tree method. Results-The analyses revealed that rs1800801 in the MGP gene (HR: 1.33, p= 9×10-03), a gene related to artery calcification, was associated with new IS during the first year of follow-up. This polymorphism was replicated in a Spanish cohort (n=1.305), however it was not significantly associated in a North American cohort (n=1.683). The GRECOS score predicted new IS (p=3.2×10-09) and could classify patients, from low risk of stroke recurrence (1.9%) to high risk (12.6%). Moreover, the addition of genetic risk factors to the GRECOS score improves the prediction compared to previous SPI-II score (p=0.03). Conclusions-The use of genetics could be useful to estimate vascular recurrence risk after IS. Genetic variability in the MGP gene was associated with vascular recurrence in the Spanish population.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants

  • Cullell, Natalia|||0000-0001-5118-1014
  • Carrera, Caty|||0000-0002-0804-0969
  • Muiño, Elena|||0000-0001-5839-7328
  • Torres, Nuria
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Oral anticoagulants (OAs) are the recommended drugs to prevent cardiovascular events and recurrence in patients with atrial fibrillation (AF) and cardioembolic stroke. We conducted a literature search to review the current state of OAs pharmacogenomics, focusing on Genome Wide Association Studies (GWAs) in patients treated with vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs). VKAs: Warfarin, acenocoumarol, fluindione and phenprocoumon have long been used, but their interindividual variability and narrow therapeutic/safety ratio makes their dosage difficult. GWAs have been useful in finding genetic variants associated with VKAs response. The main genes involved in VKAs pharmacogenetics are: VKORC1, CYP2C19 and CYP4F2. Variants in these genes have been included in pharmacogenetic algorithms to predict the VKAs dose individually in each patient depending on their genotype and clinical variables. DOACs: Dabigatran, apixaban, rivaroxaban and edoxaban have been approved for patients with AF. They have stable pharmacokinetics and do not require routine blood checks, thus avoiding most of the drawbacks of VKAs. Except for a GWAs performed in patients treated with dabigatran, there is no Genome Wide pharmacogenomics data for DOACs. Pharmacogenomics could be useful to predict the better clinical response and avoid adverse events in patients treated with anticoagulants, identifying the most appropriate anticoagulant drug for each patient. Current pharmacogenomics data show that the polymorphisms affecting VKAs or DOACs are different, concluding that personalized medicine based on pharmacogenomics could be possible. However, more studies are required to implement personalized medicine in clinical practice with OA and based on pharmacogenetics of DOACs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Muiño, Elena|||0000-0001-5839-7328
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Sobrino, Tomás|||0000-0002-9760-8690
  • Campos, Francisco|||0000-0001-8665-1039
  • Castillo, José
  • Freijo, Marimar
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Obach, Víctor|||0000-0002-0518-1053
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Molina, Carlos A.|||0000-0001-6058-6259
  • Ribo, Marc|||0000-0001-9242-043X
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Muñoz-Narbona, Lucia|||0000-0002-0884-3024
  • López-Cancio, Elena|||0000-0001-5757-9074
  • Millán Torné, Mònica|||0000-0002-4692-5936
  • Diaz-Navarro, Rosa
  • Vives-Bauza, Cristòfol
  • Serrano-Heras, Gemma|||0000-0001-9368-4832
  • Segura, Tomás|||0000-0003-3625-0987
  • Ibañez, Laura
  • Heitsch, Laura
  • Delgado, Pilar
  • Dhar, Rajat|||0000-0002-5167-5097
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Delgado Mederos, Raquel|||0000-0003-3737-7226
  • Prats Sánchez, Luis Antonio|||0000-0002-3192-4631
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Blay, Natalia|||0000-0002-7160-8529
  • Sumoy, Lauro|||0000-0003-0005-4618
  • de Cid, Rafael|||0000-0003-3579-6777
  • Montaner, Joan|||0000-0003-4845-2279
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Lee, Jim-Moo
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background: Occult atrial fibrillation (AF) is one of the major causes of embolic stroke of undetermined source (ESUS). Knowing the underlying etiology of an ESUS will reduce stroke recurrence and/or unnecessary use of anticoagulants. Understanding cardioembolic strokes (CES), whose main cause is AF, will provide tools to select patients who would benefit from anticoagulants among those with ESUS or AF. We aimed to discover novel loci associated with CES and create a polygenetic risk score (PRS) for a more efficient CES risk stratification. Methods: Multitrait analysis of GWAS (MTAG) was performed with MEGASTROKE-CES cohort (n = 362,661) and AF cohort (n = 1,030,836). We considered significant variants and replicated those variants with MTAG p-value < 5 × 10 influencing both traits (GWAS-pairwise) with a p-value < 0.05 in the original GWAS and in an independent cohort (n = 9,105). The PRS was created with PRSice-2 and evaluated in the independent cohort. Results: We found and replicated eleven loci associated with CES. Eight were novel loci. Seven of them had been previously associated with AF, namely, CAV1, ESR2, GORAB, IGF1R, NEURL1, WIPF1, and ZEB2. KIAA1755 locus had never been associated with CES/AF, leading its index variant to a missense change (R1045W). The PRS generated has been significantly associated with CES improving discrimination and patient reclassification of a model with age, sex, and hypertension. Conclusion: The loci found significantly associated with CES in the MTAG, together with the creation of a PRS that improves the predictive clinical models of CES, might help guide future clinical trials of anticoagulant therapy in patients with ESUS or AF.